| Term 
 
        | Calculate Ideal Body Weight (IBW) |  | Definition 
 
        | IBW=50+2.3(inches>60") for males IBW=45+2.3(inches>60") for females
 |  | 
        |  | 
        
        | Term 
 
        | Calculate Dosing Body Weight (DBW) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Calculate Nutrition Body Weight (NBW) |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | use if dry weight is greater than 130% of IBW generally use the same weight for all calculations in order to be consistent for FEN management
 |  | 
        |  | 
        
        | Term 
 
        | Risk factors for malnutrition |  | Definition 
 
        | UBW; 20% below IBW involuntary weight loss>10% within 6 months
 NPO>10 days (clinically we use ~7 days)
 Increased metabolic needs
 Protracted nutrient loss-->chronic disease stat
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | diet PTA, intake, swallowing, ulcers; h/o weight loss, anorexia, vomiting, diarrhea |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | decreased nutrient absorption, alter taste; increase or decrease appetite; N/V |  | 
        |  | 
        
        | Term 
 
        | Anthropometrics-Somatic(muscle) protein status |  | Definition 
 
        | weight trceps skin fold
 arm muscle circumference
 physical appearance
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | half life 18-21 days NL serum concentration: 3.5-5 gm/dL
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | half life: 8-10 days NL serum concentration: 250-300 mg/dL
 |  | 
        |  | 
        
        | Term 
 
        | Transthyretin (prealbumin) |  | Definition 
 
        | half-life=2-3 days NL serum concentration: 15-40mg/dL
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | half-life=0.5 days NL serum concentration: 2.5-7.5 gm/dL
 |  | 
        |  | 
        
        | Term 
 
        | Protein-calorie malnutrition (marasmus) |  | Definition 
 
        | decreased total intake and/or utilization of food wasting of skeletal muscle and subcutaneous fat
 immunosuppression in severe cases
 cachectic appearance
 |  | 
        |  | 
        
        | Term 
 
        | Protein malnutrition (Kwashirokor) |  | Definition 
 
        | adequate calorie intake; relative protein malnutrition catabolic trauma patients; burn patients
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | chronically ill starved patients who are metabolically stressed decreased visceral proteins, poor wound healing, immunocompromised
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | measurement of urinary excretion of nitrogen as urea nitrogen (urinary urea nitrogen) |  | 
        |  | 
        
        | Term 
 
        | Non-urinary sources of nitrogen loss |  | Definition 
 
        | sweat, feces, respirations, GI fistulas, wound drainage, skin exfoliation, burns |  | 
        |  | 
        
        | Term 
 
        | Nitrogen balance study used to assess the adequacy of protein repletion |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Formula for nitrogen balance |  | Definition 
 
        | Nitrogen balance = (N in ) - (N out) N in = 24 hour protein intake (g) / 6.25
 N out = 24 hour UUN(g) + factor (3-5g)
 use 4 g clinically
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Harris-Benedict Equation- Basal Energy Expenditure (BEE) Include "stress" or activity factory with Harris-Benedict Equation
 |  | 
        |  | 
        
        | Term 
 
        | General guidelines (total kcal/kg/day) |  | Definition 
 
        | non-stressed, non-depleted: 20-25 kcal/kg/day trauma/stress/surgery/critically ill: 25-30 kcal/kg/day
 major burn: 35-40 kcal/kg/day or more
 obesity (above 150% IBW): 22-25 kcal/kg/day (IBW)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | for all energy production, oxygen is consumed and carbon dioxide is produced abbreviated weir equation:
 REE=[39(VO2)+1.1(VCO2)]x1.44
 multiply the REE by ~1.2 to calculate the total EE
 provides energy expenditure at that ONE point in time; then extrapolated to 24 hrs: RQ=VOC2/VO2
 Goal RQ 0.85-0.95
 |  | 
        |  | 
        
        | Term 
 
        | Protein requirements for maintenance, mild to moderate stress, moderate to severe stress, burn, obesity, and severe obesity |  | Definition 
 
        | maintenance (non-hospitalized pts): 0.8-1gm/kg/day mild to moderate stress(floor pts): 1-1.5gm/kg/day
 moderate to severe stress, repletion, (ICU, trauma, surgery pts): 1.5-2gm/kg/day
 burn: 2-2.5gm/kg/day (may require more based on clinical trials)
 obesity (BMI>30): 2gm/kg/day(IBW)
 severe obesity(BMI>40):2.5gm/kg/day(IBW)
 |  | 
        |  | 
        
        | Term 
 
        | Adequate calories must be present for appropriate protein utilization |  | Definition 
 
        | adequate NPC protein "tolerance" may be decreased in some disease states (i.e. renal and hepatic failure)
 |  | 
        |  | 
        
        | Term 
 
        | Non-protein calorie (NPC) distribution |  | Definition 
 
        | standard distribution (70/30) 70-85% dextrose. 15-30% fat
 adjust based on tolerance: BS, TG, RQ
 100/0 may be utilized during sepsis and bloodstream infections
 |  | 
        |  | 
        
        | Term 
 
        | Parenteral nutrition- definition |  | Definition 
 
        | parenteral nutrition is the process of supplying nutrients (i.e. protein, carbohydrates, fat, electrolytes, vitamins, minerals) via an IV delivery system synonyms: hyperalimentation, HA, HAL, HAF, TPN, IVH, IVA, CHA(central), PHA(peripheral), PPN, total nutrient admixture, TNA, 3-in-1, triple-mix
 |  | 
        |  | 
        
        | Term 
 
        | Indications for parenteral nutrition |  | Definition 
 
        | anticipated prolonged NPO course (>7 days) inability to absorb nutrients via the gut, such as secondary to: small bowl or colonic ileus, extensive small bowel resection, malabsorptive states, intractable vomiting/diarrhea
 enterocutaneous fistulas
 inflammatory bowel disease
 hyperemesis gravidum
 bone marrow transplantation (mucositis)
 |  | 
        |  | 
        
        | Term 
 
        | Routes of administration--Peripheral TPN |  | Definition 
 
        | dextrose and amino acid solutions are hypertonic-->not well tolerated via a peripheral vein restrict final dextros conc to 5-10%, or total osmolarity to <900 mOsm/L
 addition of lipid or heparin to solution may enhance vein tolerance
 requires large volumes of fluids--> may not be the best choice for HF or RF patients
 limited in calories-->secondary to osmolality AND fluid
 short term access(<7-10 days)-->does this patient need TPN at all?
 |  | 
        |  | 
        
        | Term 
 
        | Routes of administration--Central TPN |  | Definition 
 
        | advantage-->allows adminstration of hypertonic solutions disadvantages: risk of infection->appropriate central line care is key to prevention; central line is not a benign procedure: pneumothorax, air embolus, thrombus
 |  | 
        |  | 
        
        | Term 
 
        | Central Venous Access: central venous catheter(CVC) insertion sites, short term, long term |  | Definition 
 
        | subclavian (SC), internal jugular (IJ), femoral short-term: percutaneously inserted
 long-term: PICC(peripherally inserted central catheter), tunneled, implanted port
 |  | 
        |  | 
        
        | Term 
 
        | Meeting protein requirements |  | Definition 
 
        | one gm protein=4kcal many hospitals actually order protein in gm/day
 standard amino acid products: Travasol, FreAmine III, Aminosyn II
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | max concentration available: D70% (D70W) one gram dextrose=3.4 kcal
 maximum carbohydrate utilization: 4-5 mg/kg/min (double check if needed)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | prevents essential fatty acid deficiency provides a concentrated source of calories: ~10 kcal/gm of lipids
 remember: propofol is a 10% lipid solution; provides 1.1 kcal/mL
 fat emulsion 30%: must be incorporated into a total nutrient admixture
 |  | 
        |  | 
        
        | Term 
 
        | IV fat emulsion max intake-- do not exceed |  | Definition 
 
        | 60% of caloric intake as lipid 2.5 gm/kg/d of lipid in adults
 4g/kg/d of lipids in infants and children
 |  | 
        |  | 
        
        | Term 
 
        | Essential fatty acid (EFA) requirements |  | Definition 
 
        | estimated to be 4-10% of daily calories EFAs include linoleic acid and probably linolenic acid
 |  | 
        |  | 
        
        | Term 
 
        | Essential fatty acid deficiency (EFAD) mechanism |  | Definition 
 
        | continuous infusion of hypertonic dextrose will increase circulating insulin levels inhibitors lipolysis and fatty acid mobilization
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | several weeks on a fat-free TPN regimen (10-14 days) dry, scaly skin, brittle hair, lack of luster
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | provide at least 500mL of 10% fat emulsion or 250mL of 20% fat emulsion twice weekly |  | 
        |  | 
        
        | Term 
 
        | Total Nutrient Admixture (TNA) |  | Definition 
 
        | dextrose, AA, and lipids in one bag--> "3 in 1" = TPN |  | 
        |  | 
        
        | Term 
 
        | Conventional administration |  | Definition 
 
        | dextrose and AA in one bag lipid 2-3 times a week as separate IVPB
 |  | 
        |  | 
        
        | Term 
 
        | Premix solution for injection |  | Definition 
 
        | with or without electrolytes no lipids
 |  | 
        |  | 
        
        | Term 
 
        | Initiation and discontinuation guidelines |  | Definition 
 
        | start at ~25% of goal and achieve the final rate within 24 hrs check BS q4-6h before each increase in rate, if BS>200, continue at same rate x 4 hrs and recheck, if repeat BS>200, consider insulin therapy
 cessation: decrease rate by half every 2 hrs until rate <50mL/hr, then dc
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | infusion over 10-18 hours per day patients who desire time free from infusion pump-->home TPN patients
 rate of infusion generally cut back (taper) during the last hour of infusion to prevent hypoglycemia
 |  | 
        |  | 
        
        | Term 
 
        | IV fat emulsion max intake-- do not exceed |  | Definition 
 
        | 60% of caloric intake as lipid 2.5 gm/kg/d of lipid in adults
 4g/kg/d of lipids in infants and children
 |  | 
        |  | 
        
        | Term 
 
        | Essential fatty acid (EFA) requirements |  | Definition 
 
        | estimated to be 4-10% of daily calories EFAs include linoleic acid and probably linolenic acid
 |  | 
        |  | 
        
        | Term 
 
        | Essential fatty acid deficiency (EFAD) mechanism |  | Definition 
 
        | continuous infusion of hypertonic dextrose will increase circulating insulin levels inhibitors lipolysis and fatty acid mobilization
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | several weeks on a fat-free TPN regimen (10-14 days) dry, scaly skin, brittle hair, lack of luster
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | provide at least 500mL of 10% fat emulsion or 250mL of 20% fat emulsion twice weekly |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | adult--> 10mL/d of injectable adult multivitamin-12; contains small amount of vitamin K(150mcg) pediatric (3kg-35kg)--> 2mL/d of injectable pediatric multivitamin; contains vitamin K
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mechanical (catheter-related): clotting of line, displacement Infectious: catheter-related sepsis, solution contamination, bacterial translocation
 Metabolic: electrolyte imbalance, fluid imbalance, hyper and hypoglycemia, liver function abnormalities, steatosis (fatty liver), intrahepatic cholestasis, cholelithiasis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | chem 7, Mg, Phos, Ca, hepatic function panel, prealbumin, PT/INR |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | vital signs, intake/output electrolytes (sodium, potassium, chloride, bicarbonate), glucose, BUN/Scr
 may decrease frequency when stable
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | weight, CBC, magnesium, phosphorous, calcium, prealbumin ICU setting--> increase monitoring to daily
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | albumin, transferrin, nitrogen balance, liver function test (alkaline phosphatase, AST, ALT, LDH, bilirubin), triglycerides, PT/INR Respiratory Quotient (RQ)/indirect calorimetry
 |  | 
        |  | 
        
        | Term 
 
        | Enteral nutrition-Indications |  | Definition 
 
        | Remember: "if the gut works, use it" oral consumption inadequate
 oral consumption contraindicated: esophageal obstruction, head and neck surgery, dysphagia, trauma, cerebrovascular accident, dementia
 |  | 
        |  | 
        
        | Term 
 
        | Advantages of enteral nutrition |  | Definition 
 
        | provides GI stimulation: decreases changes for bacterial translocation, stimulates biliary flow through biliary tract avoids risks associated with IVs: non-invasive placement at bedside, line infections, pneumothorax, etc.
 physiologic
 bolus feeds are more physiologic than continuous infusion
 less stringent protocol for administration
 less expensive (depending on formula)
 |  | 
        |  | 
        
        | Term 
 
        | Contraindications for enteral nutrition |  | Definition 
 
        | mechanical obstruction non-mechanical obstruction-ileus
 intractable vomiting
 severe malabsorption
 severe GI hemorrhage
 certain types of fistulas-high output, proximal small bowel
 |  | 
        |  | 
        
        | Term 
 
        | Routes of administration-EN |  | Definition 
 
        | nasogastric (NG)/Orogastric(OG) nasojejunal(NJ)/orojejunal(OJ)--Dobhoff, Cortrak/Corpak
 gastronomy: percutaneos endoscopic gastrostomy (PEG), surgical placement
 jejunostomy; PEG/PEJ
 |  | 
        |  | 
        
        | Term 
 
        | Determining route of access for EN |  | Definition 
 
        | Risk of aspiration: if low risk utilize gastric, if high risk-jejunal is preferred tolerance: vomiting, gastric residuals
 duration of therapy: long term-PEG or PEJ
 |  | 
        |  | 
        
        | Term 
 
        | methods of administration for EN-Bolus |  | Definition 
 
        | administer >200mL formula over 5-10 min requires minimal equipment (syringe
 used primarily for patients with gastrostomy-cannot feed into small bowel
 more convenient for pts-->nursing facilities, ambulatory settings
 higher risk of aspiration and intestinal SE?
 |  | 
        |  | 
        
        | Term 
 
        | methods of administration of EN-Intermittent |  | Definition 
 
        | administer >200 mL formula over 20-30 minutes (gravity drip) 4-8 feedings per day
 requires use of reservoir bottle or bag
 |  | 
        |  | 
        
        | Term 
 
        | Methods of administration of EN-continuous infusion |  | Definition 
 
        | administer continuously over 12-24 hours/day requires use of infusion pump
 preferred method when feeding into the jejunum
 gastric distention and aspiration risk may be lower
 better tolerated by the patient
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | patient characteristics: functional capacity of GI tract, underlying disease, nutritional requirements |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | adult--> 10mL/d of injectable adult multivitamin-12; contains small amount of vitamin K(150mcg) pediatric (3kg-35kg)--> 2mL/d of injectable pediatric multivitamin; contains vitamin K
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mechanical (catheter-related): clotting of line, displacement Infectious: catheter-related sepsis, solution contamination, bacterial translocation
 Metabolic: electrolyte imbalance, fluid imbalance, hyper and hypoglycemia, liver function abnormalities, steatosis (fatty liver), intrahepatic cholestasis, cholelithiasis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | chem 7, Mg, Phos, Ca, hepatic function panel, prealbumin, PT/INR |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | vital signs, intake/output electrolytes (sodium, potassium, chloride, bicarbonate), glucose, BUN/Scr
 may decrease frequency when stable
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | weight, CBC, magnesium, phosphorous, calcium, prealbumin ICU setting--> increase monitoring to daily
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | albumin, transferrin, nitrogen balance, liver function test (alkaline phosphatase, AST, ALT, LDH, bilirubin), triglycerides, PT/INR Respiratory Quotient (RQ)/indirect calorimetry
 |  | 
        |  | 
        
        | Term 
 
        | Enteral nutrition-Indications |  | Definition 
 
        | Remember: "if the gut works, use it" oral consumption inadequate
 oral consumption contraindicated: esophageal obstruction, head and neck surgery, dysphagia, trauma, cerebrovascular accident, dementia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | adult--> 10mL/d of injectable adult multivitamin-12; contains small amount of vitamin K(150mcg) pediatric (3kg-35kg)--> 2mL/d of injectable pediatric multivitamin; contains vitamin K
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mechanical (catheter-related): clotting of line, displacement Infectious: catheter-related sepsis, solution contamination, bacterial translocation
 Metabolic: electrolyte imbalance, fluid imbalance, hyper and hypoglycemia, liver function abnormalities, steatosis (fatty liver), intrahepatic cholestasis, cholelithiasis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | chem 7, Mg, Phos, Ca, hepatic function panel, prealbumin, PT/INR |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | vital signs, intake/output electrolytes (sodium, potassium, chloride, bicarbonate), glucose, BUN/Scr
 may decrease frequency when stable
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | weight, CBC, magnesium, phosphorous, calcium, prealbumin ICU setting--> increase monitoring to daily
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | albumin, transferrin, nitrogen balance, liver function test (alkaline phosphatase, AST, ALT, LDH, bilirubin), triglycerides, PT/INR Respiratory Quotient (RQ)/indirect calorimetry
 |  | 
        |  | 
        
        | Term 
 
        | Enteral nutrition-Indications |  | Definition 
 
        | Remember: "if the gut works, use it" oral consumption inadequate
 oral consumption contraindicated: esophageal obstruction, head and neck surgery, dysphagia, trauma, cerebrovascular accident, dementia
 |  | 
        |  | 
        
        | Term 
 
        | Nutrient composition- protein |  | Definition 
 
        | intact protein->requires complete digestion into smaller peptides partially digested (peptide-based)-->elemental; may be beneficial for pts with malabsorption, diarrhea
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | long-chain fatty acids medium-chain fatty acids- more water soluble; rapid hydrolysis, little or no pancreatic lipase for absorptin
 |  | 
        |  | 
        
        | Term 
 
        | Nutrient composition-carbohydrates |  | Definition 
 
        | glucose polymers primarily used for tube feeding formulas simple glucose used for oral supplements (higher in osmolality)
 |  | 
        |  | 
        
        | Term 
 
        | Initiation and advancement of EN |  | Definition 
 
        | initiate at full strength at 25mL/h advance 25mL/h q4-6h as tolerated up to goal rate
 check residuals q4-6h
 hold for residuals>400-500mL
 dilution of formula has limited benefit-->do not recommend
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | high gastric residuals diarrhea->check meds, formula
 constipation->check meds
 NV->metoclopramide, erythromycin(prokinetic) may be given
 abdominal distention
 aspiration->increase HOB 30 degrees to prevent aspiration
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | hyper-or hypoglycemia: check meds, insulin regimen, stress, infection overhydration; dehydration->monitor fluid status
 electrolyte imbalance->hyponatremia is most common
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | clogging of feeding tube: poorly crushed meds, inadequate flushing, give on pancreatic enzyme tablet and one sodium bicarbonate tablet in 10mL of warm water, clamp for 15-30 min, then flush with 15-30mL of warm water when complete tube malposition
 rhinitis: reposition daily, use smaller bore tube
 sinusitis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | gastric residuals;emesis check q4-6h
 stools daily (frequency of stools, volume of stools)
 bloating/distention
 bronchial/tracheal aspirate
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | intake/output (I/Os) weight->2-3times per week
 serum electrolytes, glucose, BUN/Scr->daily until stable->twice weekly->weekly
 Mg, Phos, Ca, TG, LFTs->weekly
 Albumin, transferrin/prealbumin, nitrogen balance-> weekly
 Mechanical: feeding tube placement, feeding tube patency
 |  | 
        |  | 
        
        | Term 
 
        | Drug delivery via Enteral feeding tubes procedure guidelines |  | Definition 
 
        | if oral dosage forms are used, crush the tablets to a fine powder or empty the contents of a capsule and mix in water Do not crush sustained-release or enteric coated formulations
 administer each drug separately, flush with at least 5mL o
 |  | 
        |  |